Skip Navigation LinksHome > Professional Development > eLearning > Hot Topics in Neonatal Transfusions

Hot Topics in Neonatal Transfusions

Please note: AABB reserves the right to make updates to this program.                          

Wednesday, April 26, 2017
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 129 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Physicians, Technologists, Nurses, Perfusionists, Laboratory Managers/Supervisors, Students/Fellows, Residents, Hospital Blood Banks
Teaching Level: Intermediate

Director/Moderator: Jan Stuckey, MS, MT(ASCP)BB, Senior Hospital Account Manager, American Red Cross – Indiana-Ohio Region, Fort Wayne, IN
Speaker: Amy E. Schmidt, MD, PhD, Assistant Professor, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, NY

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Identify special attributes of blood products/categories that are required for neonatal transfusion; e.g. age of units, anticoagulants, CMV, irradiation, quantity, ABO types, dosage, reconstitution, etc.
  • Describe alternatives to use if “fresh blood” is not available. Include risks or modifications associated with alternatives.
  • List typical transfusion complications in the neonate and potential corrective actions.
  • Review clinical situations effecting neonates that may result in transfusion of specific blood components such as NAIT, HDN, surgery, coagulopathies, AG/Ab conflicts, NEC, anemia with IUT, sickle etc.
  • Compile a list of actions to compare and contrast for potential implementation to improve neonatal services.

Program Description

Lecture format utilizing clinical case studies and/or research results will be used to establish platform for discussion of proper transfusion practices for the neonate population. In addition, hot topics associated with neonatal transfusion in clinical situations such as NAIT, NEC, anemia with IUT, HDN, and surgery that are presently under consideration and evaluation of outcomes will be discussed. Attention will be given to proper selection of blood components with appropriate attributes to treat clinical anomalies of patients with enhanced outcomes

Registration

   Program #
Single Viewer: Live Register17EL-2035-129
Single Viewer: On-Demand Register17EL-4035-129
Group Viewing: Live Register17EL-6035-129
Group Viewing: On-Demand Register17EL-8035-129
Group Viewing: Live & On-Demand Register17EL-9935-129

Speaker Biography

Dr. Amy Schmidt is the Director of the Transfusion Medicine fellowship and also the Assistant Director of Transfusion Medicine/Blood Bank.  Dr. Schmidt received her MD PhD from the Saint Louis University School of Medicine.  She completed a pediatric internship year at Lucille Packard Children’s Hospital/Stanford and completed her residency in Clinical Pathology at Barnes-Jewish Hospital/Washington University in St. Louis.  She then completed a transfusion medicine fellowship at the University of Alabama-Birmingham and a Hematopathology fellowship at SUNY Upstate.  Dr. Schmidt then served as the Director of Apheresis and Cellular Therapy at Indiana University/IUPUI.  She later joined the University of Rochester.  Her areas of research include studying microparticles, nanoparticles, and microRNA in microangiopathic hemolytic anemias as well as in burn patients.  Dr. Schmidt is board certified in clinical pathology, transfusion medicine, and Hematopathology.